A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Related studies linked through entity extraction aliases.